Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,512.38 -3.89 -0.03%
TOPIX 1,171.40 -1.97 -0.17%
HANG SENG 22,760.24 64.23 0.28%

Amyris Announces Transition of Chief Financial Officer

Amyris Announces Transition of Chief Financial Officer

Paulo Diniz, Current President of Brazil Operations, to Become Amyris's CFO
Upon Retirement of Steve Mills in December

EMERYVILLE, Calif., Nov. 15, 2013 (GLOBE NEWSWIRE) -- Amyris,
Inc. (Nasdaq:AMRS), a leading renewable chemicals and fuels company, today
announced that Paulo Diniz, currently President of Amyris Brasil, will become
Amyris's Chief Financial Officer (CFO) on an interim basis following the
decision of its current CFO, Steve Mills, to step down for personal reasons.
Mr. Diniz will assume the new responsibilities by December 15, 2013, at which
time Mr. Mills will transition to an advisory role with the Company. Amyris
has begun an executive search to evaluate potential internal and
external candidates to permanently fill the position.

"Paulo's proven track record as a CFO for leading companies and his executive
leadership as we financed, built, commissioned and now operate our
first production facility in Brazil are just some of the strong credentials
for his appointment and as we prepare to enter a promising year for Amyris,"
said John Melo, President & Chief Executive Officer of Amyris.

"Over the last two years, Steve has helped guide us through a difficult
restructuring, and has set us on stronger financial footing and a stable
growth platform. Steve has built a strong finance and accounting team and
established a robust financial discipline within our company. We wish him well
as he returns to the Midwest, and the board and I look forward to his
continuing counsel," Melo added.

"I am more confident today about Amyris's bright future than ever before, from
its inspired science to its breakthrough renewable products. I look forward
to continuing to support Amyris through my advisory role, and know Paulo is a
eminently prepared for this new stage in Amyris's progress as is the team we
have built in California and Brazil," said Mr. Mills.

Mr. Diniz will become Amyris's Chief Financial Officer upon Mr. Mills'
resignation. He joined Amyris as President of the Company's Brazilian
subsidiary in early 2011, following a successful career as, among other
things, the CFO of two agribusiness leaders: Bunge Brasil and Cosan. At Cosan,
Mr. Diniz led the successful transformation of Cosan into Brazil's largest
sugar and biofuel producer, including its initial public offering and
multiple acquisitions that paved the way for Raizen, Cosan's fuels joint
venture in Brazil with Shell.

About Amyris

Amyris is an integrated renewable products company focused on providing
sustainable alternatives to a broad range of petroleum-sourced products.
Amyris uses its industrial synthetic biology platform to convert plant sugars
into a variety of molecules -- flexible building blocks that can be used in a
wide range of products. Amyris's initial portfolio of commercial products is
based on Biofene^®, Amyris's brand of renewable farnesene, a long-chain
hydrocarbon. Amyris is commercializing these products both as No Compromise^®
renewable ingredients in cosmetics, flavors and fragrances, polymers,
lubricants and consumer products, and also as No Compromise renewable diesel
and jet fuel. Amyris Brasil Ltda., a subsidiary of Amyris, oversees the
establishment and expansion of Amyris's production in Brazil. More information
about Amyris is available at

Forward-Looking Statements

This release contains forward-looking statements, and any statements other
than statements of historical facts could be deemed to be forward-looking
statements. These forward-looking statements include, among other things,
statements regarding future events (such as executive transition plans) that
involve risks and uncertainties. These statements are based on management's
current expectations and actual results and future events may differ
materially due to risks and uncertainties, including those associated with any
delays or failures in development, production and commercialization of
products, liquidity and ability to fund capital expenditures, Amyris's
reliance on third parties to achieve its goals, and other risks detailed in
the "Risk Factors" section of Amyris's quarterly report on Form 10-Q filed on
November 5, 2013. Amyris disclaims any obligation to update information
contained in these forward-looking statements whether as a result of new
information, future events, or otherwise.

Amyris, the Amyris logo, Biofene and No Compromise are trademarks or
registered trademarks of Amyris, Inc.

CONTACT: Amyris, Inc.
         Joel Velasco
         (510) 740-7481

company logo
Sponsored Links
Sponsored Links